Literature DB >> 22945543

Epilepsy: Psychiatric adverse effects of levetiracetam linked to genetic variation in dopamine signalling.

Heather Wood.   

Abstract

Entities:  

Year:  2012        PMID： 22945543     DOI： 10.1038/nrneurol.2012.184

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam.

Authors:  Christoph Helmstaedter; Yoan Mihov; Mohammad R Toliat; Holger Thiele; Peter Nuernberg; Susanne Schoch; Rainer Surges; Christian E Elger; Wolfram S Kunz; René Hurlemann
Journal:  Epilepsia       Date:  2012-08-06       Impact factor: 5.864
  1 in total
  2 in total

1.  Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.

Authors:  Astrid Bertsche; Martina P Neininger; Anna J Dahse; Steffen Syrbe; Matthias K Bernhard; Roberto Frontini; Wieland Kiess; Thilo Bertsche; Andreas Merkenschlager
Journal:  Eur J Pediatr       Date:  2013-08-11       Impact factor: 3.183

2.  The role of dopamine signaling in epileptogenesis.

Authors:  Yuri Bozzi; Emiliana Borrelli
Journal:  Front Cell Neurosci       Date:  2013-09-17       Impact factor: 5.505
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.